查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942763

2026年全球药物涂层球囊市场报告

Drug-Coated Balloons Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物涂层球囊市场发展迅速，预计将从2025年的12.4亿美元成长到2026年的14.3亿美元，复合年增长率达15.5%。过去几年的成长可归因于心血管疾病盛行率的上升、介入性心臟病学手术的扩展、紫杉醇涂层球囊的早期应用、对预防血管再阻塞的需求不断增长以及血管成形术技术的进步。

预计未来几年药物释放型球囊市场将快速成长，到2030年市场规模将达25.5亿美元，复合年增长率（CAGR）为15.6%。预测期内的成长要素包括：冠状动脉疾病中药物洗脱球囊疗法的日益普及、新一代涂层技术的广泛应用、导管介入手术的扩展、血管治疗技术投资的增加以及对无支架治疗方法的偏好日益增强。预测期内的主要趋势包括：Sirolimus涂层球囊的日益普及、药物洗脱球囊在周边动脉疾病中的应用不断扩大、对微创血管治疗方法的偏好日益增强、先进药物涂层技术的扩展以及对提高药物输送效率的日益重视。

冠状动脉疾病（CAD）盛行率的不断上升预计将推动药物释放型球囊市场的未来成长。冠状动脉疾病的特征是为心肌供血的冠状动脉狭窄或阻塞，通常会导致心肌梗塞。药物释放型球囊是一种用于治疗冠状动脉疾病的医疗设备。它们在导管插入术期间向动脉内释放药物，以防止血管成形术后血管再阻塞（动脉血管再阻塞）。例如，2022年8月发表在《美国心臟病学会杂誌》上的一项研究预测，从2025年到2060年，美国一般人群的四大心血管危险因子均将增加。预计糖尿病的增幅最大，将达39.3%，其次是血脂异常症（27.6%）、高血压（25.1%）和肥胖（18.3%）。此外，研究预测，心臟衰竭（33.4%）和缺血性心臟疾病（30.7%）的发生率增幅最大，其次是心肌梗塞（16.9%）和中风（33.8%）。因此，冠状动脉疾病盛行率的上升预计将推动药物释放型球囊市场的发展。

药物涂层球囊领域的主要企业正致力于技术创新，包括紫杉醇涂层球囊导管，以提高冠状动脉支架内血管再阻塞等治疗的有效性。这些进展旨在改善患者预后，并最大限度地降低传统治疗方法相关併发症的风险。紫杉醇涂层球囊导管是一种特殊装置，可在扩张时将药物紫杉醇释放到动脉壁内，有助于预防血管成形术后的血管再阻塞。例如，2024年3月，美国医疗设备製造商波士顿科学公司（Boston Scientific）的AGENT™药物释放型球囊（DCB）获得了美国食品药物管理局（FDA）的核准。该装置旨在治疗冠状动脉疾病患者的冠状动脉支架内血管再阻塞（ISR），ISR是指支架植入后血管因斑块或疤痕组织而阻塞或变窄的疾病。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药物涂层球囊市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • Sirolimus涂层球囊的应用日益增多
    • 周边动脉疾病中药物涂层球囊（DCB）的应用日益增多
    • 人们越来越倾向选择微创血管手术
    • 拓展先进药包衣技术
    • 更重视提高药物传输效率

第五章 终端用户产业市场分析

  • 医院
  • 心臟导管检查室
  • 门诊手术中心
  • 介入放射中心
  • 专科心臟诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球药物涂层球囊市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球药物涂层球囊市场规模、对比及成长率分析
  • 全球药物涂层球囊市场表现：规模与成长，2020-2025年
  • 全球药物涂层球囊市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 用于治疗周边动脉疾病的药物涂层球囊，用于治疗冠状动脉疾病的药物涂层球囊
  • 依药物类型
  • 紫杉醇，Sirolimus
  • 最终用户
  • 医院、心臟导管介入检查室和门诊手术中心
  • 按类型细分：用于周边动脉疾病的药物涂层球囊
  • 紫杉醇涂层球囊，Sirolimus涂层球囊
  • 按类型细分：用于冠状动脉疾病的药物涂层球囊
  • 紫杉醇涂层球囊，Sirolimus涂层球囊

第十章 区域与国家分析

  • 全球药物涂层球囊市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球药物涂层球囊市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物涂层球囊市场：竞争格局及市场份额（2024年）
  • 药物涂层球囊市场：公司估值矩阵
  • 药物涂层球囊市场：公司简介
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Terumo Corporation

第37章：其他领先和创新企业

  • Biotronik SE & Co. KG, Biosensors International Group Ltd, Concept Medical Inc., Acotec Scientific AG, Cardionovum GmbH, MedAlliance SA, iVascular SLU, Minvasys SAS, QT Vascular Ltd, Hexacath SAS, Cordis Corporation, MicroPort Scientific Corporation, Endocor GmbH, Orchestra BioMed Inc., LEPU Medical Technology Co. Ltd

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药物涂装球囊市场：提供新机会的国家
  • 2030年药物涂装球囊市场：充满新机会的细分市场
  • 2030年药物涂层球囊市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MDCBO02_G26Q1

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

Tariffs are influencing the drug-coated balloons market by increasing costs of imported catheter materials, specialty polymers, drug-coating compounds, and precision manufacturing equipment. Hospitals and cardiac catheterization labs in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising procedure costs and slowing device adoption. At the same time, they are encouraging local manufacturing, regional R&D investments, and development of cost-optimized drug-coated balloon technologies.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from $1.24 billion in 2025 to $1.43 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, expansion of interventional cardiology procedures, early adoption of paclitaxel-coated balloons, growing demand for restenosis prevention, advancements in angioplasty techniques.

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing use of dcb therapies in coronary applications, rising adoption of next-generation coating technologies, expansion of catheter-based interventions, growing investments in vascular innovation, increasing preference for stent-free treatment options. Major trends in the forecast period include increasing adoption of sirolimus-coated balloons, rising use of dcbs in peripheral artery disease, growing preference for minimally invasive vascular treatments, expansion of advanced drug-coating technologies, enhanced focus on improved drug delivery efficiency.

The increasing prevalence of coronary artery disease (CAD) is projected to drive the growth of the drug-coated balloons market in the future. CAD is a medical condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle, often leading to heart attacks. Drug-coated balloons are medical devices used to treat coronary artery disease, releasing medication into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery following angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes is projected to see the most significant increase at 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. Additionally, the researchers found that rates of heart failure (33.4%) and ischemic heart disease (30.7%) are expected to experience the largest increases, along with heart attacks (16.9%) and strokes (33.8%). Consequently, the rise in coronary artery disease prevalence is anticipated to boost the drug-coated balloon market.

Leading companies in the drug-coated balloon sector are dedicated to advancing their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis. These advancements aim to enhance patient outcomes and minimize the risk of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the artery wall upon inflation, helping to prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for its AGENT(TM) Drug-Coated Balloon (DCB). This device is designed specifically for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a previously stented blood vessel becomes obstructed or narrowed due to plaque or scar tissue.

In October 2023, Cordis US Corp, a U.S.-based manufacturer of interventional cardiovascular technologies, acquired Med Alliance SA for an undisclosed amount, reported at approximately $1.1 billion, with total consideration of up to $1.135 billion. Through this acquisition, Cordis aims to incorporate Med Alliance's SELUTION SLR(TM) sirolimus micro-reservoir drug-coated balloon into its coronary and peripheral portfolios to accelerate market access, expand clinical development, and offer broader treatment options for patients with coronary and peripheral vascular disease. Med Alliance SA, based in Switzerland, specializes in drug-coated balloons.

Major companies operating in the drug-coated balloons market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, Biosensors International Group Ltd, Concept Medical Inc., Acotec Scientific AG, Cardionovum GmbH, MedAlliance SA, iVascular SLU, Minvasys SAS, QT Vascular Ltd, Hexacath SAS, Cordis Corporation, MicroPort Scientific Corporation, Endocor GmbH, Orchestra BioMed Inc., Lepu Medical Technology Co. Ltd, Balton Sp. z o.o., BrosMed Medical Co. Ltd

North America was the largest region in the global drug-coated balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Coated Balloons Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug-coated balloons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease
  • 2) By Drug Type: Paclitaxel; Sirolimus
  • 3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
  • 2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
  • Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Abbott Laboratories; B. Braun Melsungen AG; Terumo Corporation; Biotronik SE & Co. KG; Biosensors International Group Ltd; Concept Medical Inc.; Acotec Scientific AG; Cardionovum GmbH; MedAlliance SA; iVascular SLU; Minvasys SAS; QT Vascular Ltd; Hexacath SAS; Cordis Corporation; MicroPort Scientific Corporation; Endocor GmbH; Orchestra BioMed Inc.; Lepu Medical Technology Co. Ltd; Balton Sp. z o.o.; BrosMed Medical Co. Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug-Coated Balloons Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug-Coated Balloons Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug-Coated Balloons Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug-Coated Balloons Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Sirolimus-Coated Balloons
    • 4.2.2 Rising Use Of Dcbs In Peripheral Artery Disease
    • 4.2.3 Growing Preference For Minimally Invasive Vascular Treatments
    • 4.2.4 Expansion Of Advanced Drug-Coating Technologies
    • 4.2.5 Enhanced Focus On Improved Drug Delivery Efficiency

5. Drug-Coated Balloons Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiac Catheterization Labs
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Interventional Radiology Centers
  • 5.5 Specialty Cardiology Clinics

6. Drug-Coated Balloons Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug-Coated Balloons Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug-Coated Balloons PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug-Coated Balloons Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug-Coated Balloons Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug-Coated Balloons Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug-Coated Balloons Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug-Coated Balloons Market Segmentation

  • 9.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease
  • 9.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Paclitaxel, Sirolimus
  • 9.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers
  • 9.4. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Peripheral Artery Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
  • 9.5. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Coronary Artery Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

10. Drug-Coated Balloons Market Regional And Country Analysis

  • 10.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug-Coated Balloons Market

  • 11.1. Asia-Pacific Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug-Coated Balloons Market

  • 12.1. China Drug-Coated Balloons Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug-Coated Balloons Market

  • 13.1. India Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug-Coated Balloons Market

  • 14.1. Japan Drug-Coated Balloons Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug-Coated Balloons Market

  • 15.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug-Coated Balloons Market

  • 16.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug-Coated Balloons Market

  • 17.1. South Korea Drug-Coated Balloons Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug-Coated Balloons Market

  • 18.1. Taiwan Drug-Coated Balloons Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug-Coated Balloons Market

  • 19.1. South East Asia Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug-Coated Balloons Market

  • 20.1. Western Europe Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug-Coated Balloons Market

  • 21.1. UK Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug-Coated Balloons Market

  • 22.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug-Coated Balloons Market

  • 23.1. France Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug-Coated Balloons Market

  • 24.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug-Coated Balloons Market

  • 25.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug-Coated Balloons Market

  • 26.1. Eastern Europe Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug-Coated Balloons Market

  • 27.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug-Coated Balloons Market

  • 28.1. North America Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug-Coated Balloons Market

  • 29.1. USA Drug-Coated Balloons Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug-Coated Balloons Market

  • 30.1. Canada Drug-Coated Balloons Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug-Coated Balloons Market

  • 31.1. South America Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug-Coated Balloons Market

  • 32.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug-Coated Balloons Market

  • 33.1. Middle East Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug-Coated Balloons Market

  • 34.1. Africa Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Segmentation By Drug Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug-Coated Balloons Market Regulatory and Investment Landscape

36. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

  • 36.1. Drug-Coated Balloons Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug-Coated Balloons Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug-Coated Balloons Market Company Profiles
    • 36.3.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Drug-Coated Balloons Market Other Major And Innovative Companies

  • Biotronik SE & Co. KG, Biosensors International Group Ltd, Concept Medical Inc., Acotec Scientific AG, Cardionovum GmbH, MedAlliance SA, iVascular SLU, Minvasys SAS, QT Vascular Ltd, Hexacath SAS, Cordis Corporation, MicroPort Scientific Corporation, Endocor GmbH, Orchestra BioMed Inc., LEPU Medical Technology Co. Ltd

38. Global Drug-Coated Balloons Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

40. Drug-Coated Balloons Market High Potential Countries, Segments and Strategies

  • 40.1 Drug-Coated Balloons Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug-Coated Balloons Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug-Coated Balloons Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer